EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxidative stress changes the effectiveness of artemisinin in Plasmodium falciparum

Camilla Valente Pires iD, Debora Cassandra, Shulin Xu, Benoit Laleu, Jeremy N Burrows, John H Adams iD

mBio · 13.03.2024 · 15 (3)

DOI: 10.1128/mbio.03169-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 13.03.2024. Verfasst von Camilla Valente Pires und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Global Health and Interdisciplinary Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tam…. Hauptthemen laut MEDLINE: Antimalarials, Artemisinins, Malaria, Falciparum, Malaria. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria parasites have adaptive mechanisms to modulate their intracellular redox status to tolerate the enhanced oxidizing effects created by malaria fever, hemoglobinopathies and other stress conditions, including antimalaria drugs. Emerging artemisinin (ART) resistance in Plasmodium falciparum is a complex phenotype linked to the parasite’s tolerance of the activated drug’s oxidative damage along with changes in vesicular transport, lipid metabolism, DNA repair, and exported proteins. In an earlier study, we discovered that many of these metabolic processes are induced in P. falciparum to respond to the oxidative damage caused by artemisinin, which exhibited a highly significant overlap with the parasite’s adaptive response mechanisms to survive febrile temperatures. In addition, there was a significant overlap with the parasite’s survival responses to oxidative stress. In this study, we investigated these relationships further using an in vitro model to evaluate if oxidative stress and heat-shock conditions could alter the parasite’s response to artemisinin. The results revealed that compared to ideal culture conditions, the antimalarial efficacy of artemisinin was significantly reduced in parasites growing in intraerythrocytic oxidative stress but not in heat-shock condition. In contrast, heat shock significantly reduced the efficacy of lumefantrine that is an important ART combination therapy partner drug. We propose that prolonged exposure to intraerythrocytic microenvironmental oxidative stress, as would occur in endemic regions with high prevalence for sickle trait and other hemoglobinopathies, can predispose malaria parasites to develop tolerance to the oxidative damage caused by antimalarial drugs like artemisinin. IMPORTANCE Emerging resistance to the frontline antimalarial drug artemisinin represents a significant threat to worldwide malaria control and elimination. The patterns of parasite changes associated with emerging resistance represent a complex array of metabolic processes evident in various genetic mutations and altered transcription profiles. Genetic factors identified in regulating P. falciparum sensitivity to artemisinin overlap with the parasite’s responses to malarial fever, sickle trait, and other types of oxidative stresses, suggesting conserved inducible survival responses. In this study we show that intraerythrocytic stress conditions, oxidative stress and heat shock, can significantly decrease the sensitivity of the parasite to artemisinin and lumefantrine, respectively. These results indicate that an intraerythrocytic oxidative stress microenvironment and heat-shock condition can alter antimalarial drug efficacy. Evaluating efficacy of antimalarial drugs under ideal in vitro culture conditions may not accurately predict drug efficacy in all malaria patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsArtemisininsMalaria, FalciparumMalariaFolic Acid AntagonistsHemoglobinopathiesAnemia, Sickle CellHumansPlasmodium falciparumLumefantrineDrug CombinationsProtozoan ProteinsOxidative StressDrug Resistance

Stichwörter der Autor:innen

antimalarial agentsartemisindrug resistance evolutionmalariaoxidative stress

Substanzen

AntimalarialsartemisininArtemisininsLumefantrineDrug CombinationsProtozoan ProteinsFolic Acid Antagonists

Autor:innen und Institutionen

  • Center for Global Health and Interdisciplinary Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, Tampa, Florida, USA.
  • Medicines for Malaria Venture, ICC, Geneva, Switzerland.

ORCID-Profile: Camilla Valente Pires, John H Adams

Förderung

  • NIAID NIH HHS
  • HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Pires, C. V., Cassandra, D., Xu, S., Laleu, B., Burrows, J. N., & Adams, J. H. (2024). Oxidative stress changes the effectiveness of artemisinin in Plasmodium falciparum. mBio, 15(3). https://doi.org/10.1128/mbio.03169-23

Vancouver

Pires CV, Cassandra D, Xu S, Laleu B, Burrows JN, Adams JH. Oxidative stress changes the effectiveness of artemisinin in Plasmodium falciparum. mBio. 2024;15(3). doi:10.1128/mbio.03169-23

BibTeX
@article{Pires2024,
  author = {Pires, Camilla Valente and Cassandra, Debora and Xu, Shulin and Laleu, Benoit and Burrows, Jeremy N and Adams, John H},
  title = {Oxidative stress changes the effectiveness of artemisinin in Plasmodium falciparum},
  journal = {mBio},
  year = {2024},
  volume = {15},
  number = {3},
  doi = {10.1128/mbio.03169-23}
}
Kostenlos starten →